Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|June 7, 2021
Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus VulgarisVictoria P Werth, Pascal Joly, Daniel Mimouni, et al.
International Journal of Dermatology|April 10, 2022
Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral centerIris Amitay-Laish, Efrat Solomon-Cohen, Hana Feuerman, et al.
Journal of the American Academy of Dermatology|July 10, 2004
Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodiesDaniel Mimouni, Dagmar Foedinger, Dave J Kouba, et al.
The Israel Medical Association Journal : IMAJ|May 13, 2024
A Comparison of Hidradenitis Suppurativa Characteristics Among Israeli Arabs and Jews: Analysis of Two CohortsJen Barak Levitt, Shira Barmatz, Shira Fisch-Gilad, et al.
Clinical and Experimental Dermatology|October 31, 2025
Vitiligo-like leukoderma following treatment with cyclin-dependent kinase 4/6 inhibitors - analysis of clinicopathologic and immunohistochemical findingsMaya Engler Markowitz, Rotem Merose, Elena Didkovski, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
Journal of the American Academy of Dermatology|March 15, 2008
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusDedee F Murrell, Sarah Dick, A R Ahmed, et al.
Journal of the American Academy of Dermatology|November 8, 2011
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of expertsDedee F Murrell, Benjamin S Daniel, Pascal Joly, et al.
Pageof 15